Biomedical Engineering Reference
In-Depth Information
167. Laforest, M.D. et al., Pharmacokinetics and biodistribution of technium 99m labelled standard
heparin and a low molecular weight heparin (enoxaparin) after intravenous injection in normal volunteers,
Br. J. Haematol
., 77, 201, 1991.
168. Manson, L. et al., The variable anticoagulant response to unfractionated heparin
in vivo
refl ects binding
to plasma proteins rather than clearance,
J. Lab. Clin. Med
., 130, 649, 1997.
169. Young, E. et al., Induction of the acute-phase reaction increases heparin-binding proteins in plasma,
Arterioscler. Thromb. Vasc. Biol
., 17, 1568, 1997.
170. Messmore, H.L. et al.,
In vitro
studies of the interaction of heparin, low molecular weight heparin and
heparinoids with platelets,
NY Acad. Sci
., 556, 217, 1989.
171. Patton, W.A. 2nd. et al., Identifi cation of a heparin-binding protein using monoclonal antibodies that
block heparin binding to porcine aortic endothelial cells,
Biochem. J
., 311, 461, 1995.
172. Lijnen, H.R., Hoylaerts, M., and Collen, D., Heparin binding properties of human histidine-rich gly-
coprotein: Mechanism and role in the neutralization of heparin in plasma,
J. Biol. Chem
., 258, 3803,
1983.
173. Teoh, K.H. et al., Heparin binding proteins. Contribution to heparin rebound after cardiopulmonary
bypass,
Circulation
, 88, 420, 1993.
174. Young, E. et al.,
Ex-vivo
and
in-vitro
evidence that low molecular weight heparins exhibit less binding
to plasma proteins than unfractionated heparin,
Thromb. Haemost
., 71, 300, 1994.
175. Cosmi, B. et al., Effect of nonspecifi c binding to plasma proteins on the antithrombin activities of
unfractionated heparin, low-molecular-weight heparin, and dermatan sulfate,
Circulation
, 95, 118,
1997.
176. Hogg, P.J. and Jackson, C.M., Heparin promotes the binding of thrombin to fi brin polymer. Quantita-
tive characterization of a thrombin-fi brin polymer-heparin ternary complex,
J. Biol. Chem
., 265, 241,
1990.
177. Hogg, P.J. et al., Binding of fi brin monomer and heparin to thrombin in a ternary complex alters the
environment of the thrombin catalytic site, reduces affi nity for hirudin and inhibits cleavage of fi brino-
gen,
J. Biol. Chem
., 271, 26088, 1996.
178. Hogg, P.J. and Jackson, C.M., Fibrin monomer protects thrombin from inactivation by heparin-
antithrombin III: Implications for heparin effi cacy,
Proc. Natl Acad. Sci. USA
, 86, 3619, 1989.
179. Hogg, P.J. and Jackson, C.M., Formation of a ternary complex between thrombin, fi brin monomer, and
heparin infl uences the action of thrombin on its substrates,
J. Biol. Chem
., 265, 248, 1990.
180. Bendayan, P. et al., Dermatan sulphate is a more potent inhibitor of clot-bound thrombin than unfrac-
tionated and low molecular weight heparins,
Thromb. Haemost
., 71, 576, 1994.
181. Rezaie, A.R., Prothrombin protects factor Xa in the prothrombinase complex from inhibition by the
heparin-antithrombin complex,
Blood
, 97, 2308, 2001.
182. Brufatto, N. and Nesheim, M.E., The use of prothrombin(S525C) labeled with fl uorescein to directly
study the inhibition of prothrombinase by antithrombin during prothrombin activation,
J. Biol. Chem
.,
276, 17663, 2001.
183. Cohen, M., Heparin-induced thrombocytopenia and the clinical use of low molecular weight heparins
in acute coronary syndromes,
Semin. Hematol
., 36, 33, 1999.
184. Hull, R.D. et al., Optimal therapeutic level of heparin therapy in patients with venous thrombosis,
Arch.
Intern. Med
., 152, 1589, 1992.
185. Hirsh, J., Salzman, E.W., and Marder, V.J., Treatment of venous thromboembolism, in
Hemostasis
and Thrombosis: Basic Principles and Clinical Practice
, Colman, R.W., Hirsh, J., Marder, V.J., and
Salzman, E.W., Eds., J. P. Lippincott Company, New York, 1994, chap. 69.
186. Koopman, M.M. et al., Treatment of venous thrombosis with intravenous unfractionated heparin admin-
istered in the hospital as compared with subcutaneous low molecular weight heparin administered at
home. The Tasman Study Group,
N. Engl. J. Med
., 334, 682, 1996.
187. Levine, M. et al., A comparison of low molecular weight heparin administered primarily at home with
unfractionated heparin administered in the hospital for proximal deep venous thrombosis,
N. Engl. J.
Med
., 334, 677, 1996.
188. Warkentin, T. et al., Heparin-induced thrombocytopenia in patients treated with low molecular weight
heparins or unfractionated heparin,
N. Engl. J. Med
., 332, 1330, 1995.
189. Dahlman, T., Lindvall, N., and Hellgren, M., Osteopenia in pregnancy during longterm heparin treat-
ment: A radiological study
post partum,
Br. J. Obstet. Gynaecol
., 97, 221, 1990.
190. Barbour, L.A. et al., A prospective study of heparin-induced osteoporosis in pregnancy using bone
densitometry,
Am. J. Obstet. Gynecol
., 170, 862, 1994.
